Azenta (AZTA)

• Market cap: $1.42B
• 1 day: 0.59%
• 5 days: 3.34%
• 1 month: -9.35%
• 3 months: 11.62%
• 6 months: -34.23%
• Year to date: -38.17%
• 1 year: -37.60%
• 5 years: -40.58%
• 10 years: 204.23%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Employees: 3,000

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

15% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 89

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0.18% less ownership

Funds ownership: 115.07% [Q1] → 114.9% (-0.18%) [Q2]

7% less funds holding

Funds holding: 292 [Q1] → 272 (-20) [Q2]

11% less capital invested

Capital invested by funds: $1.82B [Q1] → $1.62B (-$200M) [Q2]

18% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 65

69% less call options, than puts

Call options by funds: $855K | Put options by funds: $2.76M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $33 7% upside
• Avg. target: $34 10% upside
• High target: $35 13% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Raymond James Andrew Cooper	13% upside $35	Outperform Upgraded	6 Aug 2025
Evercore ISI Group Vijay Kumar	7% upside $33	In-Line Maintained	5 Aug 2025